Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=oxgnLatest Financial News for OXiGENE, Inc.en-usMon, 7 Dec 2009 14:49:09 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091207/179796.html?.v=1yahoo_finance/3909162864Mon, 7 Dec 2009 14:49:09 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091120/oxgn8-k.htmlyahoo_finance/525196301Fri, 20 Nov 2009 19:43:46 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091117/us_oxigene_study.html?.v=2Development-stage biotechnology company Oxigene Inc. said Tuesday its lung cancer treatment candidate Zybrestat met safety goals in a midstage study.yahoo_finance/1476460365Tue, 17 Nov 2009 18:44:37 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091117/178573.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today reported positive interim safety data from the FALCON study, a Phase 2, randomized, controlled study of ZYBRESTAT in patients with advanced non-small cell lung cancer .yahoo_finance/3910149794Tue, 17 Nov 2009 17:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=oxgnyahoo_finance/3242634890Sat, 14 Nov 2009 14:04:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091112/178317.html?.v=1yahoo_finance/4111268325Thu, 12 Nov 2009 21:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091110/oxgn10-q.htmlyahoo_finance/2058609527Tue, 10 Nov 2009 20:38:41 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091110/178014.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that OXiGENE Management will present a corporate overview and update at the Merriman Curhan Ford Investor Summit at 12:00 noon EST today at the Sofitel Hotel in New York City, N.Y.yahoo_finance/194580955Tue, 10 Nov 2009 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091109/oxgn8-k.htmlyahoo_finance/928826896Mon, 9 Nov 2009 13:54:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/research/earncal/20091109.html?t=oxgnyahoo_finance/950947298Mon, 9 Nov 2009 12:07:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091109/177885.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, reported financial results for the quarter and nine months ended September 30, 2009 and presented an update on recent clinical and corporate progress.yahoo_finance/453676018Mon, 9 Nov 2009 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091103/177268.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report third quarter 2009 results on Monday, November 9th, 2009.yahoo_finance/3058900329Tue, 3 Nov 2009 07:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091102/oxgn8-k_a.htmlyahoo_finance/59755177Mon, 2 Nov 2009 21:44:26 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091016/oxgn8-k.htmlyahoo_finance/3292708891Fri, 16 Oct 2009 21:30:51 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091015/175565.html?.v=1SOUTH SAN FRANCISCO, Calif. -- OXiGENE, Inc. , a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, and VaxGen, Inc. , a biopharmaceutical company, announced today that they have entered into a definitive merger agreement pursuant to which OXiGENE will acquire VaxGen in exchange for common stock of OXiGENE.yahoo_finance/3222944693Thu, 15 Oct 2009 10:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091012/175207.html?.v=1yahoo_finance/580428235Mon, 12 Oct 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091009/oxgn8-k.htmlyahoo_finance/1832819543Fri, 9 Oct 2009 19:38:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091008/175029.html?.v=1yahoo_finance/1865060310Thu, 8 Oct 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/090730/oxgn8-k.htmlyahoo_finance/2781098067Thu, 30 Jul 2009 12:11:02 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/090730/170225.html?.v=1yahoo_finance/763772896Thu, 30 Jul 2009 06:00:00 Etc/GMT